| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a98cb1b197f761c87cd3caf32bc247e2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7064
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7064
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2020-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25ffa8a509fcafcdb5d7da77f4d34f8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44d00655d0169c60ce16087587d201fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4fd1003aba5109a7ccd4484d2f36663 |
| publicationDate |
2022-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-112021025443-A2 |
| titleOfInvention |
Phosphate ester compounds with a pyrrolopyrimidine skeleton or a pharmaceutically acceptable salt thereof, antitumor agents and pharmaceutical compositions comprising said compounds, as well as therapeutic uses and uses thereof |
| abstract |
novel pyrrolopyrimidine backbone phosphate ester compound or pharmaceutically acceptable salt thereof. There is provided a novel phosphate ester compound having a pyrrolopyrimidine backbone having an excellent antitumor effect or a pharmaceutically acceptable salt thereof, and a method of preventing and/or treating a tumor in combination with an alkylating agent and/or a cancer therapy. radiation. According to one aspect of the present invention, there is provided a compound represented by the following general formula (1) or a pharmaceutically acceptable salt thereof, and a method of preventing and/or treating a tumor in combination with an alkylating agent and/or or radiation therapy. |
| priorityDate |
2019-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |